Ubs Group Ag Vyant Bio, Inc. Transaction History

Ubs Group Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.52 - $0.89 $1,795 - $3,073	-3,453 Reduced 19.8%	13,984 $8,000
Q2 2022 Aug 10, 2022	BUY	$0.62 - $1.37 $5,051 - $11,162	8,148 Added 87.72%	17,437 $16,000
Q1 2022 May 16, 2022	SELL	$0.99 - $1.61 $744 - $1,210	-752 Reduced 7.49%	9,289 $13,000
Q4 2021 Feb 14, 2022	BUY	$1.32 - $2.96 $13,254 - $29,721	10,041 New	10,041 $14,000
Q3 2021 Nov 15, 2021	SELL	$2.26 - $3.74 $2,935 - $4,858	-1,299 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.88 - $4.81 $1,393 - $2,328	484 Added 59.39%	1,299 $5,000
Q1 2021 May 12, 2021	BUY	$2.89 - $8.6 $2,355 - $7,009	815 New	815 $4,000

213K

Ticker VYNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,343,200
Description
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.